Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3118)
All Articles published online
|
Dec 14, 2006 (publication date) through Jul 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lei YC, Tian YJ, Ding HH, Wang BJ, Yang Y, Hao YH, Zhao XP, Lu MJ, Gong FL, Yang DL. N-terminal and C-terminal cytosine deaminase domain of APOBEC3G inhibit hepatitis B virus replication. World J Gastroenterol 2006; 12(46): 7488-7496 [PMID: 17167839 DOI: 10.3748/wjg.v12.i46.7488] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i46/7488.htm |
| Number | Citing Articles |
| 1 |
Klaus Strebel, Jeremy Luban, Kuan-Teh Jeang. Human cellular restriction factors that target HIV-1 replication. BMC Medicine 2009; 7(1) doi: 10.1186/1741-7015-7-48
|
| 2 |
Jianbo Xia, Weipeng Wang, Lei Li, Zhi Liu, Min Liu, Dongliang Yang. Inhibition of HBV replication by VPS4B and its dominant negative mutant VPS4B-K180Q in vivo. Journal of Huazhong University of Science and Technology [Medical Sciences] 2012; 32(3): 311 doi: 10.1007/s11596-012-0054-2
|
| 3 |
XIUTING HE, JIE LI, JING WU, MANLI ZHANG, PUJUN GAO. Associations between activation-induced cytidine deaminase/apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like cytidine deaminase expression, hepatitis B virus (HBV) replication and HBV-associated liver disease (Review). Molecular Medicine Reports 2015; 12(5): 6405 doi: 10.3892/mmr.2015.4312
|
| 4 |
Eri Miyagi, Charles R. Brown, Sandrine Opi, Mohammad Khan, Ritu Goila-Gaur, Sandra Kao, Robert C. Walker, Vanessa Hirsch, Klaus Strebel. Stably Expressed APOBEC3F Has Negligible Antiviral Activity. Journal of Virology 2010; 84(21): 11067 doi: 10.1128/JVI.01249-10
|
| 5 |
E. M. Janahi, M. J. McGarvey. The inhibition of hepatitis B virus by APOBEC cytidine deaminases. Journal of Viral Hepatitis 2013; 20(12): 821 doi: 10.1111/jvh.12192
|
| 6 |
Tongtong Zhu, Guangyi Niu, Yuansheng Zhang, Ming Chen, Chuan-Yun Li, Lili Hao, Zhang Zhang. Host-mediated RNA editing in viruses. Biology Direct 2023; 18(1) doi: 10.1186/s13062-023-00366-w
|
| 7 |
Yang Deng, Yan Du, Qi Zhang, Xue Han, Guangwen Cao. Human cytidine deaminases facilitate hepatitis B virus evolution and link inflammation and hepatocellular carcinoma. Cancer Letters 2014; 343(2): 161 doi: 10.1016/j.canlet.2013.09.041
|
| 8 |
Nika Lovšin, Bhavani Gangupam, Martina Bergant Marušič. The Intricate Interplay between APOBEC3 Proteins and DNA Tumour Viruses. Pathogens 2024; 13(3): 187 doi: 10.3390/pathogens13030187
|
| 9 |
Yuan Zhang, Xiaorong Chen, Yajuan Cao, Zongguo Yang. Roles of APOBEC3 in hepatitis B virus (HBV) infection and hepatocarcinogenesis. Bioengineered 2021; 12(1): 2074 doi: 10.1080/21655979.2021.1931640
|
| 10 |
Michel Henry, Denise Guétard, Rodolphe Suspène, Christophe Rusniok, Simon Wain-Hobson, Jean-Pierre Vartanian, Peter Sommer. Genetic Editing of HBV DNA by Monodomain Human APOBEC3 Cytidine Deaminases and the Recombinant Nature of APOBEC3G. PLoS ONE 2009; 4(1): e4277 doi: 10.1371/journal.pone.0004277
|